2 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Withdrawn 2 |
Follow Chikungunya Fever: new trials by email Literature Review of Chikungunya Fever trials Research Report on Chikungunya Fever
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Evaluate the Safety and Immunogenicity of VLA1553 in Healthy Children VLA1553, Control - Chikungunya Virus Infection | Phase 3 | Withdrawn | Valneva Austria GmbH | 2026-02-06 | 2025-12-31 | |
| A Clinical Phase 3 Trial of VLA1553 in Adult Participants with Human Immunodeficiency Virus (HIV) VLA1553 - Chikungunya Virus Infection | Phase 3 | Withdrawn | Valneva Austria GmbH | 2024-04-10 | 2024-12-02 |
Alphavirus Infections (2) · Arbovirus Infections (2) · Infections (2) · Mosquito-Borne Diseases (2) · RNA Virus Infections (2) · Togaviridae Infections (2) · Vector Borne Diseases (2) · Virus Diseases (2)